As anticipated, Western blot results demonstrated that KLF5 expression was higher in ovarian cancer tissues compared to normal fallopian tube tissues (Fig. 2E) and high KLF5 expression levels demonstrated correlations with both poorer overall survival (Fig. 2G) and progression-free survival (Fig. 2H) in ovarian cancer patients. This evidence concerns the gene KLF5 and ovarian cancer.